NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled
NCT00073944 2013-05-30BCX-1777 in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1 Completed